March 7, 2018 / 11:28 AM / 5 months ago

BRIEF-Ligand Pharma Says‍ Underreported Potential Aggregate Milestone Payments Related To License Agreement With Roivant Sciences

March 7 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND PHARMACEUTICALS SAYS‍ UNDERREPORTED POTENTIAL AGGREGATE MILESTONE PAYMENTS RELATED TO LICENSE AGREEMENT WITH ROIVANT SCIENCES FOR LGD-6972​

* LIGAND PHARMA SAYS UNDER AGREEMENT, CO TO RECEIVE POTENTIAL LICENSE & MILESTONE PAYMENTS OF UP TO $548.8 MILLION - SEC FILING Source text: (bit.ly/2I7Qw0U) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below